Litcius/Paper detail

Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma

Teng Wei, Matthias Leisegang, Ming Xia, Kazuma Kiyotani, Furong Li, Chenquan Zeng, Chunyan Deng, Jinxing Jiang, Makiko Harada, Nishant Agrawal, Liangping Li, Hui Qi, Yusuke Nakamura, Lili Ren

2021OncoImmunology33 citationsDOIOpen Access PDF

Abstract

-specific TCR T cells destroyed human tumors in mice. The established protocol provides the required flexibility to methods striving to identify neoantigen-specific TCRs. By using an MHC-matched APC cell line and neoantigen-encoding minigene libraries, autologous TILs can be stimulated and screened when patient PBMCs and/or tumor material are not available anymore. Abbreviations: Head and neck squamous cell carcinoma (HNSCC); adoptive T cell therapy (ACT); T cell receptor (TCR); tumor-infiltrating lymphocytes (TIL); cytotoxic T lymphocyte (CTL); peripheral blood mononuclear cell (PBMC); dendritic cell (DC); antigen-presenting cells (APC).

Topics & Concepts

T-cell receptorAdoptive cell transferT cellMinigeneHead and neck squamous-cell carcinomaImmunologyCytotoxic T cellCancer researchImmunotherapyAntigen-presenting cellAntigenMedicineBiologyImmune systemCancerHead and neck cancerIn vitroInternal medicineRNABiochemistryRNA splicingGeneCAR-T cell therapy researchImmunotherapy and Immune ResponsesVirus-based gene therapy research
Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma | Litcius